Over the past week the consortium has been working hard to investigate production of a range of ventilator design options to meet a high-level specification for a Rapidly Manufactured Ventilator System (“RMVS”) developed by clinicians and the Medicines and Healthcare products Regulatory Agency (“MHRA”).
The consortium has evaluated all requirements to design, manufacture, assemble and test components, as well as finished medical ventilators.
Companies in the consortium have now received formal orders from the Government.
The consortium will now accelerate production of an agreed new design, based on existing technologies, which can be assembled from materials and parts in current production. The device combines existing proven clinical equipment and is the clinicians’ first choice for the RMVS.
The Ashurst team was led by partners Chris Bates and Rob Aird, working alongside McLaren Group General Counsel, Tim Murnane.
The VentilatorChallengeUK Consortium is chaired by Dick Elsy, CEO of the High Value Manufacturing Catapult. Companies and Groups involved include Airbus, BAE Systems, Ford Motor Company, GKN Aerospace, High Value Manufacturing Catapult, Inspiration Healthcare Group, McLaren Automotive, Applied and Racing, Meggitt, Penlon, Renishaw, Rolls-Royce, Siemens Healthineers and Siemens UK, Smiths Group, Thales, Ultra Electronics, Unilever and UK-based F1 teams: Haas F1, Mercedes, Red Bull Racing, Racing Point, Renault Sport Racing and Williams.